InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: KMC-1 post# 128873

Thursday, 09/30/2021 1:57:19 PM

Thursday, September 30, 2021 1:57:19 PM

Post# of 199220
ENZC milestones cliffnotes from first 20 minutes:
Hit me with corrections, I typed these live and have no rewind button yet.


ITV-1
- will be completing production in October, then clinical trials
- trials expected to be expedited because of Bulgarian data
- EU market by 2022

AI
- identified conserved sites, now creating mAbs for all 8 sites for HIV
- 19 covid conserved sites, confirmed target sites the same on the first five covid variants
- conserved sites for about 20 other infectious diseases, will add to ip portfolio
- discussing animal mAbs collabs, veterinary market by Q4 2022

Fully human mAbs
- preclinical success at Strausburg and Montana
- expanded team of scientists
- confident there will be good animal study results, based on earlier primate studies by Fauci
- have partnered with CDMO to start making mAbs (for studies first, maybe more later)
- have partnered with same CDMO to produce material for animal studies
- have selected partner for animal studies & hope to report that result "early next year"

"On track" with the uplisting. Hope to uplist the stock "very soon"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News